mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.05 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.06 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.06 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.06 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.06 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |